Urol. praxi. 2023;24(4):243-245 | DOI: 10.36290/uro.2023.088

Current pharmacotherapy options for erectile dysfunction

MUDr. Marcela Čechová, Ph.D., FEBU
Urologická klinika 2. LF UK a FN Motol, Praha

Erectile dysfunction is one of the most common complaint affecting middle-aged and older men. In common urological practice this represents a frequent reason for visiting specialist, thus thus awareness of causes and treatment options is highly desired. Text briefly summarises current possibilities of pharmacotherapy. options of pharmacotherapy.

Keywords: erectile dysfunction, pharmacotherapy, phosphodiesterase type 5 inhibitors, alprostadil.

Accepted: November 27, 2023; Published: November 30, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čechová M. Current pharmacotherapy options for erectile dysfunction. Urol. praxi. 2023;24(4):243-245. doi: 10.36290/uro.2023.088.
Download citation

References

  1. Salonia A, Minhas S, Betocchi C, et al. Sexual and Reproductive Health. EAU Guidelines. Arnhem: EAU Guidelines Office; 2023. Dostupné také z: https://uroweb.org/guidelines/sexual-and-reproductive-health.
  2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. Go to original source... Go to PubMed...
  3. Goldstein I, Goren A, Li VW, et al. Sex Med Rev. 2020;8(1): 48-58. Go to original source... Go to PubMed...
  4. Pozzi E, Capogrosso P, Boeri L, et al. Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction - Which Patients Deserve More Attention? J Sex Med. 2020;17(8):1489-1494. Go to original source... Go to PubMed...
  5. SPC jednotlivých léčivých přípravků, dostupné z Databáze léků. Státní ústav pro kontrolu léčiv [online], SÚKL: ©2010 [cit. 15.06.2023]. Dostupné na: https://www.sukl.cz/.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.